Deroy & Devereaux Private Investment Counsel Inc Organon & Co. Transaction History

Deroy & Devereaux Private Investment Counsel Inc

$1.75 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $18.3 Million - $23.7 Million	-601,171 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$28.67 - $37.13 $346,993 - $449,384	-12,103 Reduced 1.97%	601,171 $18.3 Million
Q3 2021 Oct 20, 2021	BUY	$28.63 - $35.64 $4.29 Million - $5.34 Million	149,839 Added 32.33%	613,274 $20.1 Million
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $13.2 Million - $17.6 Million	463,435 New	463,435 $14 Million

Others Institutions Holding OGN

# of Institutions

813

Shares Held

202M

Call Options Held

1.53M

Put Options Held

1.07M

Black Rock Inc. New York, NY

32.6M
Shares

$468 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.4M
Shares

$436 Million
0.01% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.2M
Shares

$160 Million
0.41% of portfolio
Massachusetts Financial Services CO Boston, MA

9.9M
Shares

$142 Million
0.05% of portfolio
State Street Corp Boston, MA

9.34M
Shares

$134 Million
0.01% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.65B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deroy & Devereaux Private Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deroy & Devereaux Private Investment Counsel Inc with notifications on news.

Account